Aclaris Therapeutics Inc (ACRS)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: ACRS Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-05 2024-03-04 B Purchase

Powell Andrew Kenneth William

Non-Executive Director
6,000 +26.2%
1.25
7,500 USD 		6,000 +26.2% 1.25 7,500 USD
2024-03-05 2024-03-01 B Purchase

Powell Andrew Kenneth William

Non-Executive Director
8,500 +59.2%
1.23
10,455 USD 		8,500 +59.2% 1.23 10,455 USD
2023-10-25 2023-10-23 PS Planned sale

Monahan Joseph

Chief Scientific Officer

Officer
6,000 -4.4%
5.08
30,460 USD 		6,000 -4.4% 5.08 30,460 USD
2023-09-07 2023-09-06 B Purchase

Balthaser Kevin

Chief Financial Officer

Officer
9,490 +158.9%
7.90
74,971 USD 		9,490 +158.9% 7.90 74,971 USD
2023-08-28 2023-08-28 B Purchase

Loerop James

Chief Business Officer

Officer
14,705 +210.6%
6.80
99,959 USD 		14,705 +210.6% 6.80 99,959 USD
2023-08-22 2023-08-21 PS Planned sale

Monahan Joseph

Chief Scientific Officer

Officer
6,000 -4.2%
7.32
43,895 USD 		6,000 -4.2% 7.32 43,895 USD
2023-06-22 2023-06-20 PS Planned sale

Monahan Joseph

Chief Scientific Officer

Officer
6,000 -4.1%
10.28
61,663 USD 		6,000 -4.1% 10.28 61,663 USD
2023-03-17 2023-03-17 B Purchase

Manion Douglas J.

Pres and CEO

Executive Director
6,300 +96.9%
7.86
49,532 USD 		6,300 +96.9% 7.86 49,532 USD
2023-03-09 2023-03-09 B Purchase

Manion Douglas J.

Pres and CEO

Executive Director
6,500 +inf%
7.74
50,278 USD 		6,500 +inf% 7.74 50,278 USD
2023-03-03 2023-03-03 S Sale

Balthaser Kevin

Chief Financial Officer

Officer
894 -14.5%
12.63
11,290 USD 		894 -14.5% 12.63 11,290 USD
2023-03-03 2023-03-03 S Sale

Walker Neal

Non-Executive Director
30,240 -2.3%
12.63
382,070 USD 		30,240 -2.3% 12.63 382,070 USD
2023-03-03 2023-03-03 S Sale

Monahan Joseph

Chief Scientific Officer

Officer
16,037 -9.8%
12.63
202,615 USD 		16,037 -9.8% 12.63 202,615 USD
2023-03-03 2023-03-02 S Sale

Balthaser Kevin

Chief Financial Officer

Officer
1,000 -17.7%
12.29
12,289 USD 		1,000 -17.7% 12.29 12,289 USD
2023-03-03 2023-03-02 S Sale

Walker Neal

Non-Executive Director
29,000 -2.2%
12.37
358,588 USD 		29,000 -2.2% 12.37 358,588 USD
2023-03-03 2023-03-02 S Sale

Monahan Joseph

Chief Scientific Officer

Officer
14,800 -8.9%
12.37
183,024 USD 		14,800 -8.9% 12.37 183,024 USD
2023-02-17 2023-02-15 PS Planned sale

Monahan Joseph

Chief Scientific Officer

Officer
5,000 -5.2%
13.06
65,311 USD 		5,000 -5.2% 13.06 65,311 USD
2023-02-10 2023-02-08 S Sale

Loerop James

Chief Business Officer

Officer
4,267 -37.9%
13.89
59,272 USD 		4,267 -37.9% 13.89 59,272 USD
2023-02-03 2023-02-02 PS Planned sale

Walker Neal

Non-Executive Director
200 -0.0%
17.54
3,507 USD 		200 -0.0% 17.54 3,507 USD
2023-02-03 2023-02-02 PS Planned sale

Walker Neal

Non-Executive Director
3,121 -0.3%
16.88
52,691 USD 		3,121 -0.3% 16.88 52,691 USD
2023-02-03 2023-02-02 PS Planned sale

Walker Neal

Non-Executive Director
600 -0.1%
15.55
9,332 USD 		600 -0.1% 15.55 9,332 USD
2023-02-03 2023-02-02 PS Planned sale

Walker Neal

Non-Executive Director
1,079 -0.1%
14.57
15,718 USD 		1,079 -0.1% 14.57 15,718 USD
2023-02-03 2023-02-01 PS Planned sale

Walker Neal

Non-Executive Director
25,000 -2.1%
16.75
418,675 USD 		25,000 -2.1% 16.75 418,675 USD
2023-01-04 2023-01-04 PS Planned sale

Walker Neal

Non-Executive Director
15,000 -1.2%
14.89
223,343 USD 		15,000 -1.2% 14.89 223,343 USD
2023-01-04 2023-01-03 PS Planned sale

Walker Neal

Non-Executive Director
1,618 -0.1%
16.16
26,146 USD 		1,618 -0.1% 16.16 26,146 USD
2023-01-04 2023-01-03 PS Planned sale

Walker Neal

Non-Executive Director
23,382 -1.9%
15.19
355,067 USD 		23,382 -1.9% 15.19 355,067 USD
2022-12-16 2022-12-15 PS Planned sale

Monahan Joseph

Chief Scientific Officer

Officer
5,000 -4.9%
15.88
79,412 USD 		5,000 -4.9% 15.88 79,412 USD
2022-11-14 2022-11-14 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
1,371 -0.3%
17.08
23,417 USD 		1,371 -0.3% 17.08 23,417 USD
2022-11-14 2022-11-11 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
41,160 -8.6%
17.06
702,177 USD 		41,160 -8.6% 17.06 702,177 USD
2022-11-14 2022-11-10 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
11,395 -2.3%
17.02
193,995 USD 		11,395 -2.3% 17.02 193,995 USD
2022-10-26 2022-10-26 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
14,540 -2.9%
17.01
247,253 USD 		14,540 -2.9% 17.01 247,253 USD
2022-10-26 2022-10-25 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
12,018 -2.3%
17.02
204,516 USD 		12,018 -2.3% 17.02 204,516 USD
2022-10-26 2022-10-24 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
14,616 -2.8%
17.01
248,586 USD 		14,616 -2.8% 17.01 248,586 USD
2022-10-19 2022-10-18 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
32,093 -5.7%
16.89
542,022 USD 		32,093 -5.7% 16.89 542,022 USD
2022-10-19 2022-10-17 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
19,944 -3.4%
16.05
320,087 USD 		19,944 -3.4% 16.05 320,087 USD
2022-10-19 2022-10-17 PS Planned sale

Monahan Joseph

Chief Scientific Officer

Officer
5,000 -4.7%
15.98
79,908 USD 		5,000 -4.7% 15.98 79,908 USD
2022-10-11 2022-10-07 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
7,324 -1.2%
16.16
118,349 USD 		7,324 -1.2% 16.16 118,349 USD
2022-10-06 2022-10-06 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
37,839 -6.0%
16.54
625,744 USD 		37,839 -6.0% 16.54 625,744 USD
2022-10-06 2022-10-04 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
7,700 -1.2%
16.01
123,259 USD 		7,700 -1.2% 16.01 123,259 USD
2022-06-21 2022-06-17 PS Planned sale

SCHIFF ANDREW N

Non-Executive Director
19,565 -100.0%
15.14
296,269 USD 		19,565 -100.0% 15.14 296,269 USD
2022-04-25 2022-04-25 PS Planned sale

Walker Neal

President and CEO

Executive Director
20,000 -1.6%
15.18
303,656 USD 		20,000 -1.6% 15.18 303,656 USD
2022-04-25 2022-04-22 PS Planned sale

Walker Neal

President and CEO

Executive Director
25,000 -1.9%
15.04
376,098 USD 		25,000 -1.9% 15.04 376,098 USD
2022-04-25 2022-04-21 PS Planned sale

Walker Neal

President and CEO

Executive Director
25,000 -1.9%
15.24
380,948 USD 		25,000 -1.9% 15.24 380,948 USD
2022-04-20 2022-04-18 PS Planned sale

Monahan Joseph

Chief Scientific Officer

Officer
30,000 -22.0%
16.28
488,298 USD 		30,000 -22.0% 16.28 488,298 USD
2022-03-14 2022-03-11 S Sale

Walker Neal

President and CEO

Executive Director
56,303 -4.1%
15.91
896,045 USD 		56,303 -4.1% 15.91 896,045 USD
2022-03-14 2022-03-10 S Sale

Ruffo Frank

Chief Financial Officer

Officer
12,823 -6.0%
15.55
199,335 USD 		12,823 -6.0% 15.55 199,335 USD
2022-03-14 2022-03-10 S Sale

Monahan Joseph

Chief Scientific Officer

Officer
27,165 -16.6%
15.71
426,803 USD 		27,165 -16.6% 15.71 426,803 USD
2022-02-11 2022-02-09 S Sale

Ruffo Frank

Chief Financial Officer

Officer
1,388 -0.8%
12.66
17,568 USD 		1,388 -0.8% 12.66 17,568 USD
2022-02-11 2022-02-09 S Sale

Monahan Joseph

Chief Scientific Officer

Officer
383 -0.4%
12.68
4,857 USD 		383 -0.4% 12.68 4,857 USD
2022-02-11 2022-02-09 S Sale

Walker Neal

President and CEO

Executive Director
3,595 -0.3%
12.66
45,513 USD 		3,595 -0.3% 12.66 45,513 USD
2021-06-04 2021-06-03 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
9,492 -7.2%
21.96
208,421 USD 		9,492 -7.2% 21.96 208,421 USD
2021-06-02 2021-06-02 S Sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
2,387 -1.8%
22.31
53,257 USD 		2,387 -1.8% 22.31 53,257 USD
2021-06-02 2021-06-02 S Sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
12,732 -8.7%
21.51
273,822 USD 		12,732 -8.7% 21.51 273,822 USD
2021-06-02 2021-06-02 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
2,517 -1.7%
22.32
56,173 USD 		2,517 -1.7% 22.32 56,173 USD
2021-06-02 2021-06-02 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
12,483 -7.7%
21.50
268,412 USD 		12,483 -7.7% 21.50 268,412 USD
2021-06-02 2021-06-02 S Sale

Ruffo Frank

Chief Financial Officer

Officer
2,450 -1.4%
22.30
54,635 USD 		2,450 -1.4% 22.30 54,635 USD
2021-06-02 2021-06-02 S Sale

Ruffo Frank

Chief Financial Officer

Officer
12,587 -6.8%
21.51
270,748 USD 		12,587 -6.8% 21.51 270,748 USD
2021-06-02 2021-06-02 S Sale

Gordon David N.

Chief Medical Officer

Officer
6,800 -4.5%
22.26
151,401 USD 		6,800 -4.5% 22.26 151,401 USD
2021-06-02 2021-06-02 S Sale

Gordon David N.

Chief Medical Officer

Officer
31,114 -17.1%
21.50
668,808 USD 		31,114 -17.1% 21.50 668,808 USD
2021-06-02 2021-06-02 S Sale

Monahan Joseph

Chief Scientific Officer

Officer
3,550 -4.0%
22.31
79,205 USD 		3,550 -4.0% 22.31 79,205 USD
2021-06-02 2021-06-02 S Sale

Monahan Joseph

Chief Scientific Officer

Officer
18,240 -17.0%
21.50
392,231 USD 		18,240 -17.0% 21.50 392,231 USD
2021-06-02 2021-06-02 S Sale

Walker Neal

President and CEO

Executive Director
5,517 -0.4%
22.30
123,038 USD 		5,517 -0.4% 22.30 123,038 USD
2021-06-02 2021-06-02 S Sale

Walker Neal

President and CEO

Executive Director
27,743 -2.2%
21.51
596,696 USD 		27,743 -2.2% 21.51 596,696 USD
2021-06-02 2021-06-01 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
5,254 -3.1%
23.57
123,851 USD 		5,254 -3.1% 23.57 123,851 USD
2021-06-02 2021-06-01 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
9,746 -5.5%
22.72
221,448 USD 		9,746 -5.5% 22.72 221,448 USD
2021-06-02 2021-06-01 PS Planned sale

Gordon David N.

Chief Medical Officer

Officer
4,885 -2.6%
23.57
115,142 USD 		4,885 -2.6% 23.57 115,142 USD
2021-06-02 2021-06-01 PS Planned sale

Gordon David N.

Chief Medical Officer

Officer
9,115 -4.7%
22.71
207,024 USD 		9,115 -4.7% 22.71 207,024 USD
2021-05-05 2021-05-05 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
498 -0.3%
24.36
12,129 USD 		498 -0.3% 24.36 12,129 USD
2021-05-05 2021-05-05 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
14,502 -9.1%
23.97
347,584 USD 		14,502 -9.1% 23.97 347,584 USD
2021-05-05 2021-05-04 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
1,279 -0.9%
24.47
31,296 USD 		1,279 -0.9% 24.47 31,296 USD
2021-05-05 2021-05-04 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
13,721 -8.7%
23.61
323,891 USD 		13,721 -8.7% 23.61 323,891 USD
2021-05-05 2021-05-03 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
4,339 -2.9%
24.91
108,074 USD 		4,339 -2.9% 24.91 108,074 USD
2021-05-05 2021-05-03 PS Planned sale

Ali-Jackson Kamil

Chief Legal Officer

Officer
10,661 -6.7%
24.46
260,745 USD 		10,661 -6.7% 24.46 260,745 USD
2021-04-26 2021-04-26 PS Planned sale

Ruffo Frank

Chief Financial Officer

Officer
100 -0.1%
26.44
2,644 USD 		100 -0.1% 26.44 2,644 USD
2021-04-26 2021-04-26 PS Planned sale

Ruffo Frank

Chief Financial Officer

Officer
27,239 -15.2%
25.79
702,584 USD 		27,239 -15.2% 25.79 702,584 USD
2021-04-26 2021-04-23 PS Planned sale

Ruffo Frank

Chief Financial Officer

Officer
800 -0.4%
27.33
21,863 USD 		800 -0.4% 27.33 21,863 USD